Kite’s Maryland CAR T-cell therapy site gets FDA go-ahead

Kite, a Gilead company, says the US Food and Drug Administration (FDA) has approved commercial production at the company's new CAR T-cell therapy manufacturing facility in Frederick, Maryland.